SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE

Patent Owner

Watch Compare Add to Portfolio 3Status Updates

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 56201
 
 
 
C07K PEPTIDES 26109
 
 
 
C07D HETEROCYCLIC COMPOUNDS 24137
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 14150
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 12182
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 9125
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 8116
 
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 547
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 489
 
 
 
C07F ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM, OR TELLURIUM 369

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0342,088 NOVEL ULK1 INHIBITORS AND METHODS USING SAMEAug 25, 15Nov 30, 17[C07D, C12Q, A61K, C07K]
2017/0334,889 COMPOUNDS AND METHODS FOR ACTIVATING THE APOPTOTIC ARM OF THE UNFOLDED PROTEIN RESPONSEAug 09, 17Nov 23, 17[C07D, C07C, A61K]
2017/0326,245 Methods and Compositions Related To Annexin 1-Binding CompoundsApr 04, 17Nov 16, 17[A61K]
2017/0313,668 METHODS AND COMPOSITIONS RELATED TO RETINOID RECEPTOR-SELECTIVE PATHWAYFeb 16, 17Nov 02, 17[C07D, C07C, G01N, A61K]
2017/0240,514 Small Molecule Agonists of Neurotensin Receptor 1Jun 24, 15Aug 24, 17[C07D]
2017/0217,951 Metabotropic Glutamate Receptor Negative Allosteric Modulators (NAMS) and Uses ThereofJun 09, 15Aug 03, 17[C07D]
2017/0196,879 Use of Inhibitor of Apoptosis Protein (IAP) Antagonists in HIV TherapyJun 04, 15Jul 13, 17[A61K]
2017/0198,047 PSGL-1 MODULATORS AND USES THEREOFJul 08, 15Jul 13, 17[C07K]
2017/0182,095 METHODS AND COMPOSITIONS TO MODULATE HAIR GROWTHJul 07, 15Jun 29, 17[C12N, A61K]
2017/0166,972 LONG NON-CODING RNA AS A DIAGNOSTIC AND THERAPEUTIC AGENTNov 26, 14Jun 15, 17[C12N, C12Q]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9783576 Compositions and methods for targeted endometriosis treatmentJun 11, 14Oct 10, 17[A61K, C07K]
9776979 EBI2 modulatorsSep 26, 14Oct 03, 17[C07F, C07D]
9732067 Compounds and methods for activating the apoptotic arm of the unfolded protein responseJun 18, 13Aug 15, 17[C07D, C07C, A61K]
9610359 Methods and compositions related to annexin 1-binding compoundsDec 23, 10Apr 04, 17[A61P, A61K, C07K]
9611235 Methods and compositions related to a retinoid receptor-selective pathwayMay 06, 11Apr 04, 17[C07D, C07C, G01N, A61K]
9598402 Quinazolinone analogs and use of quinazolinone analogs for treating or preventing certain viral infectionsAug 10, 12Mar 21, 17[C07D, A61K]
9581598 Diagnosis and treatment of brain tumorApr 25, 13Feb 28, 17[C12N, G01N, A61K, C07K]
9546174 Inhibitor of apoptosis protein (IAP) antagonistsNov 26, 13Jan 17, 17[C07D]
9526693 Delivery of agents using interfering nanoparticlesMar 16, 11Dec 27, 16[C12N, A61K]
9522198 Methods and compositions related to targeting tumors and woundsJul 14, 14Dec 20, 16[A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0022,831 Peptides that Selectively Home to Heart Vasculature and Related Conjugates and MethodsABANMar 22, 15Jan 28, 16[A61K, C07K]
2015/0266,964 METHODS FOR ACCELERATING IMMUNE REGENERATIONABANOct 04, 13Sep 24, 15[C07K]
2015/0051,138 INHIBITORS OF FURIN AND OTHER PRO-PROTEIN CONVERTASESABANMar 14, 13Feb 19, 15[C07K]
2014/0243,387 METHODS FOR IMPROVING CARDIAC CONTRACTILITYABANDec 17, 13Aug 28, 14[C12N, G01N]
2014/0134,231 MIR-211 EXPRESSION AND RELATED PATHWAYS IN HUMAN MELANOMAABANMar 15, 13May 15, 14[C12N, C12Q, A61K]
2014/0005,181 SMALL MOLECULE ANTAGONISTS OF THE APELIN RECEPTOR FOR THE TREATMENT OF DISEASEABANJun 20, 13Jan 02, 14[C07D]
2013/0224,182 BCL-G POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USEABANSep 28, 11Aug 29, 13[C07K]
2013/0225,427 METHOD FOR PREDICTION OF RESPONSE TO IMMUNE MEDIATED DISEASE THERAPEUTICSABANNov 07, 12Aug 29, 13[C12Q, G01N]
2013/0210,124 DETERMINATION OF CANCER PREDISPOSITIONABANFeb 08, 13Aug 15, 13[G06F]
2013/0183,241 PEPTIDES THAT HOME TO TUMOR LYMPHATIC VASCULATURE AND METHODS OF USING SAMEABANDec 10, 12Jul 18, 13[A61K]
2013/0157,260 IDENTIFICATION OF COMPOUNDS THAT REGULATE APOPTOSISABANDec 02, 10Jun 20, 13[G01N]
2013/0136,786 LONG NON-CODING RNA SPRY4-IT1 AS A DIAGNOSTIC AND THERAPEUTIC AGENTABANFeb 09, 12May 30, 13[C12N, C12Q]
2013/0100,272 Multifunction autofocus system and method for automated microscopyABANOct 25, 11Apr 25, 13[H04N]
2013/0084,328 METHYLATED CODING AND NON-CODING RNA GENES AS DIAGNOSTIC AND THERAPEUTIC TOOLS FOR HUMAN MELANOMAABANApr 26, 12Apr 04, 13[C12Q]
2013/0064,799 METHODS FOR PROMOTING CELL REPROGRAMMINGABANMay 31, 12Mar 14, 13[C12N, C40B, G01N, A61K]
2013/0058,993 METHODS AND COMPOSITIONS FOR ENHANCING WOUND HEALING USING CAR PEPTIDESABANFeb 28, 12Mar 07, 13[A61P, A61K, B82Y, C07K]
2012/0276,122 METHODS FOR DIAGNOSIS AND TREATMENT OF CELLULAR PROLIFERATIVE DISORDERSABANOct 31, 11Nov 01, 12[C40B, A61P, C12Q, G01N, A61K, C07K]
2012/0269,901 Methods and Compounds Useful to Induce Apoptosis in Cancer CellsABANDec 19, 11Oct 25, 12[A61P, G01N, A61K]
2012/0219,502 METHODS AND COMPOSITIONS FOR TARGETING GC1QR/P32ABANApr 17, 12Aug 30, 12[A61P, C12Q, A61K, G01N]
2012/0204,273 COMPOSITIONS RELATING TO A PHOSPHOPROTEIN AND METHODS OF USEABANDec 22, 11Aug 09, 12[C12N, A01K, A61P, C12Q, G01N, A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.